Found: 10
Select item for more details and to access through your institution.
Pediatrician intervention impacts parental smoking in cystic fibrosis, diabetes, and bronchiolitis.
- Published in:
- Pediatric Pulmonology, 2021, v. 56, n. 6, p. 1716, doi. 10.1002/ppul.25277
- By:
- Publication type:
- Article
Increased Fecal Calprotectin Is Associated with Worse Gastrointestinal Symptoms and Quality of Life Scores in Children with Cystic Fibrosis.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 12, p. 4080, doi. 10.3390/jcm9124080
- By:
- Publication type:
- Article
Transition des patients atteints d'une maladie respiratoire chronique depuis la pédiatrie vers les services pour adultes: L'exemple de la mucoviscidose.
- Published in:
- Médecine Sciences, 2023, v. 39, n. 1, p. 58, doi. 10.1051/medsci/2022200
- By:
- Publication type:
- Article
Moving the Dial on Airway Inflammation in Response to Trikafta in Adolescents with Cystic Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 207, n. 6, p. 792, doi. 10.1164/rccm.202210-1938LE
- By:
- Publication type:
- Article
Educational and health outcomes associated with bronchopulmonary dysplasia in 15-year-olds born preterm.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0222286
- By:
- Publication type:
- Article
Management of initial colonisations with Burkholderia species in France, with retrospective analysis in five cystic fibrosis Centres: a pilot study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Reduced Intestinal Inflammation With Lumacaftor/Ivacaftor in Adolescents With Cystic Fibrosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized Therapy.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 3, p. 333, doi. 10.1007/s40262-023-01342-3
- By:
- Publication type:
- Article
Higher levels of Pseudomonas aeruginosa LasB elastase expression are associated with early-stage infection in cystic fibrosis patients.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41333-9
- By:
- Publication type:
- Article
Higher levels of Pseudomonas aeruginosa LasB elastase expression are associated with early-stage infection in cystic fibrosis patients.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41333-9
- By:
- Publication type:
- Article